找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiovascular Genetics for Clinicians; P. A. Doevendans,A. A. M. Wilde Book 2001 Springer Science+Business Media Dordrecht 2001 DNA.ather

[復(fù)制鏈接]
51#
發(fā)表于 2025-3-30 10:48:03 | 只看該作者
52#
發(fā)表于 2025-3-30 15:16:07 | 只看該作者
Genetics of Hypertensionly understood. It is generally felt that different factors may contribute in an individual patient. Among those that have been intensively studied are salt intake, obesity and insulin resistance, the renin-angiotensin system, and the sympathetic nervous system. In the past few years, research has be
53#
發(fā)表于 2025-3-30 16:52:27 | 只看該作者
Lipoproteins and Atherosclerosisis, or the molecular origin, of a disorder and the insight into the way genetic information is expressed or modulated by the environment, will have a major impact on treatment and prevention of disease. This approach, complete elucidation of the molecular basis, unequivocal diagnosis, optimized trea
54#
發(fā)表于 2025-3-30 21:15:17 | 只看該作者
Homocysteine, Genetic Determinants and Cardiovascular Riskypertension, diabetes mellitus and smoking cannot fully explain the great number of patients with cardiovascular disease. Classic homocystinuria due to a deficiency in cystathionine — synthase (CBS) is a rare inborn error of metabolism resulting in very high blood levels of homocysteine. Such patien
55#
發(fā)表于 2025-3-31 03:17:48 | 只看該作者
Genetic Markers of Hemostatic Factorsture of an atherosclerotic plaque, endothelial cell damage, or both, are the key events that trigger the thrombotic process. Plaque disruption is followed by the exposure of blood flow to tissue factor (TF), a glycoprotein elaborated by several cells infiltrating the plaque, which is accumulated esp
56#
發(fā)表于 2025-3-31 05:16:44 | 只看該作者
The Pharmacogenetics Of Atherosclerosismade in unraveling the basis of atherosclerosis. Presently, atherosclerosis is considered to have a complex pathophysiology.in which inflammation is most important [1]. Advances also have been made in both primary and secondary prevention of complications of atherosclerosis like myocardial infarctio
57#
發(fā)表于 2025-3-31 09:40:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 05:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泰顺县| 蕉岭县| 张家口市| 赣榆县| 高阳县| 阆中市| 大冶市| 晋城| 措勤县| 威远县| 韶关市| 宿松县| 格尔木市| 湘潭县| 澜沧| 仁怀市| 红桥区| 会理县| 平顺县| 绥芬河市| 永定县| 子长县| 台安县| 红安县| 达孜县| 邢台县| 四子王旗| 衡阳市| 宜丰县| 博爱县| 延长县| 丹棱县| 新源县| 玉树县| 青河县| 铁岭市| 监利县| 尼勒克县| 柘荣县| 平江县| 简阳市|